|Articles|August 10, 2010
EGA Talks Biosimilars
The European Generic Medicines Association's Director for Scientific Affairs, Suzette Cox, talks to us about the environment for biosimilars.
Advertisement
Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Eli Lilly Enters $8.5 Billion Strategic Collaboration with Innovent Biologics and Acquires Orna Therapeutics
2
Hims & Hers Pulls Access to Compounded Semaglutide Pill Following Controversial Launch
3
Articulating the Long-Term Value of AI-Powered Approaches
4
TrumpRx Is Live and Complicated
5